Subsequently, several reports revealed that the iNOS-derived NO might play a pivotal role in the adaptation and survival of breast (100, 114–117), glioma (103, 118, 119), and prostate (120) cancer cells to 5-ALA-PDT oxidative stress. The gene discussed is NOS2; the disease is cancer.